A polyarticular juvenile idiopathic arthritis treatment that offers possibilities for symptom relief.

If your child has been diagnosed with moderate to severe polyarticular juvenile idiopathic arthritis (JIA), it may be time to ask about HUMIRA.

As the parent of a child with JIA, you know how frustrating it can be when your child is experiencing symptoms such as:

  • Painful, swollen, and tender joints
  • Joint stiffness that’s worse in the morning

These symptoms may cause changes in your child’s behavior such as a reluctance to use their arms and legs. Symptoms of juvenile idiopathic arthritis may also cause difficulty walking.

Dad and his son talking with the doctor.

HUMIRA can help relieve the symptoms of moderate to severe polyarticular JIA.

  • Since its FDA approval for the treatment of moderate to severe polyarticular juvenile idiopathic arthritis, HUMIRA has helped many patients find improvement in their symptoms
  • During a 32-week period of a clinical study in patients 4-17 years of age, fewer children treated with HUMIRA (both alone and in combination with methotrexate) experienced disease flare compared with those who did not receive HUMIRA
  • In the same study in patients 4-17 years of age, more children treated with HUMIRA plus methotrexate had at least a 70% improvement in their polyarticular juvenile idiopathic arthritis symptoms at Week 48 compared with those who took methotrexate without HUMIRA

HUMIRA is a treatment that may help to reduce the signs and symptoms of moderate to severe polyarticular JIA, even in children who have not been helped enough by other non-biologic medications. HUMIRA can be used alone or with methotrexate.

Talk to your child's pediatric rheumatologist today to find out if HUMIRA may be an option. If your child doesn't have a pediatric rheumatologist yet, ask your child's doctor to help you find one.